Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Aplex Bio AB
AB
Active
Org 5592482870
Nobels Väg 16, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 6 years old
10-19 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Aplex Bio AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (2)
UN
Umear Naseem
Chief Executive Officer
Chief Executive Officer
2021
ME
Marcus Emanuel Öhrn
Audit
Audit
2021
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (3)
MB
Mats Bo Johan Nilsson Bernitz
Board of Directors
Board of Directors
2022
LE
Lars Erik Jonas Wallberg
Chairman
Chairman
2021
RB
Rolf Bertil Ehrnström
Board of Directors
Board of Directors
2024
Former (6)
NH
Nils Henrik Kristoffer Svensson
Deputy Board Member
Deputy Board Member
2020 – 2021
LA
Lina Anna Elisabeth Nordström
Deputy Board Member
Deputy Board Member
2020 – 2021
ZU
Zubair Uddin Naseem
Deputy Board Member
Deputy Board Member
2021 – 2022
NM
Nina Marika Wodzinski
Board of Directors
Board of Directors
2020 – 2021
HD
Henrik Daniel Karlsson
Deputy Board Member
Deputy Board Member
2020 – 2021
BH
Bo Hammarlund
Board of Directors
Board of Directors
2021 – 2024
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Naseem Ventures AB
Company
51%
51%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Aplex Bio AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
